BioWorld

Dec. 22, 2004

View Archived Issues

Arena Forms Deal Worth Up To $612M With Ortho-McNeil

Arena Pharmaceuticals Inc. takes a case-by-case approach when it comes to partnering its drug candidates. If the economics are right, the San Diego-based company will sign on the dotted line. (BioWorld Today) Read More

Vicuron's NDA For Antibiotic Dalbavancin In FDA's Hands

Read More

Receptors, Signal Transduction Determine Range Of Viral Host

Read More

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Read More

Cell Therapeutics Raises $18.5M, Forms Quintiles Trisenox Deal

Read More

Other News To Note

Read More